Sensorion Operating Margin from 2010 to 2026
| ALSEN Stock | EUR 0.31 0.01 3.13% |
Check Sensorion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sensorion's main balance sheet or income statement drivers, such as Depreciation And Amortization of 992.6 K, Interest Expense of 246.5 K or Selling General Administrative of 10.6 M, as well as many indicators such as Price To Sales Ratio of 29.66, Dividend Yield of 0.0 or PTB Ratio of 2.74. Sensorion financial statements analysis is a perfect complement when working with Sensorion Valuation or Volatility modules.
Sensorion | Operating Margin |
Evaluating Sensorion's Operating Margin across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Sensorion SA's fundamental strength.
Latest Sensorion's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Sensorion SA over the last few years. It is Sensorion's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sensorion's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (7.22) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Sensorion Operating Margin Regression Statistics
| Arithmetic Mean | (3,642) | |
| Coefficient Of Variation | (279.10) | |
| Mean Deviation | 6,354 | |
| Median | (4.97) | |
| Standard Deviation | 10,165 | |
| Sample Variance | 103.3M | |
| Range | 30.6K | |
| R-Value | 0.56 | |
| Mean Square Error | 75.5M | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | 1,129 | |
| Total Sum of Squares | 1.7B |
Sensorion Operating Margin History
About Sensorion Financial Statements
Sensorion shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Sensorion investors may analyze each financial statement separately, they are all interrelated. The changes in Sensorion's assets and liabilities, for example, are also reflected in the revenues and expenses on on Sensorion's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Sensorion SA, a clinical-stage biopharmaceutical company, develops therapies for the treatment of inner ear disorders in France. The company was founded in 2009 and is headquartered in Montpellier, France. SENSORION operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 33 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sensorion Stock Analysis
When running Sensorion's price analysis, check to measure Sensorion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensorion is operating at the current time. Most of Sensorion's value examination focuses on studying past and present price action to predict the probability of Sensorion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensorion's price. Additionally, you may evaluate how the addition of Sensorion to your portfolios can decrease your overall portfolio volatility.